Riboflavin and cancer: a review.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D001391:Azo Compounds; D001551:Benz(a)Anthracenes; D001835:Body Weight; D002478:Cells, Cultured; D004848:Epithelium / Q000473:pathology; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism; D008727:Methotrexate / Q000378:metabolism; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000150:complications; D012256:Riboflavin / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D012257:Riboflavin Deficiency / Q000150:complications / Q000473:pathology; D014184:Transplantation, Homologous
D000227:Adenine Nucleotides; D001391:Azo Compounds; D001551:Benz(a)Anthracenes; D005493:Folic Acid Antagonists; D012256:Riboflavin; D008727:Methotrexate